Setmelanotide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The most common research dosage for Setmelanotide is 1-3 mg daily, administered once daily via subcutaneous injection. Typical cycles run ongoing continuous therapy. With a half-life of not publicly disclosed, timing matters for optimal results.
What Is Setmelanotide and Why Does Dosing Matter?
Setmelanotide (Setmelanotide (MC4R agonist)) is a Melanocortin-4 receptor agonist. Developed by Rhythm Pharmaceuticals as first-in-class MC4R agonist for genetic obesity. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.
The standard research dosage for Setmelanotide has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.
What Is the Recommended Setmelanotide Dosage?
The most widely used Setmelanotide dosage is 1-3 mg daily, administered once daily via subcutaneous injection.
Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of Setmelanotide is not publicly disclosed, which directly determines how often you need to dose to maintain stable blood levels.
For Setmelanotide specifically, the ongoing continuous therapy cycle length is standard. Longer isn't always better — Melanocortin-4 receptor agonist compounds require cycling to maintain receptor sensitivity.
When Should You Dose Setmelanotide?
With a half-life of not publicly disclosed, timing your Setmelanotide administration affects peak blood levels. Most protocols call for once daily.
For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.
Calculate Your Setmelanotide Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Setmelanotide.
Open Calculator →How Do You Reconstitute Setmelanotide?
Setmelanotide typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.
Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.
How Long Should a Setmelanotide Cycle Last?
Standard Setmelanotide cycles run ongoing continuous therapy. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.
Phase 3 TRANSCEND trial: -18.4% placebo-adjusted BMI reduction at 52 weeks. FDA approved November 2020 for genetic obesity (POMC/PCSK1/LEPR deficiency). March 2026 expanded for acquired hypothalamic obesity.
What Side Effects Can Affect Dosing?
Hyperpigmentation (skin, moles, lips) most common — reversible upon discontinuation. Injection site reactions, nausea, headache. Generally well-tolerated.
If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most Setmelanotide-related side effects are dose-dependent.
How Does Setmelanotide Dosing Change When Stacking?
Not typically stacked due to direct MC4R activation bypassing upstream defects.
When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.
What Is the Bottom Line on Setmelanotide Dosing?
Start at 1, dose once daily, and run cycles of ongoing continuous therapy. Monitor your response and adjust within the established range.
Source matters — always use research-grade Setmelanotide from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.
Related Reading
- Setmelanotide Benefits
- Setmelanotide Side Effects
- Setmelanotide Stacking Guide
- Setmelanotide Cycle Guide
- Setmelanotide Research
- ARA-290 Complete Guide
Research-Grade Sourcing
If you're going to research Setmelanotide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Setmelanotide?
Setmelanotide (Setmelanotide (MC4R agonist)) is a Melanocortin-4 receptor agonist. Developed by Rhythm Pharmaceuticals as first-in-class MC4R agonist for genetic obesity. It is researched for weight loss in genetic obesity, appetite reduction, energy expenditure increase, BMI reduction.
What is the recommended Setmelanotide dosage?
Common dosages: 1-3 mg daily administered once daily via subcutaneous injection. Cycle length: ongoing continuous therapy. Half-life: not publicly disclosed. Use our peptide calculator for exact reconstitution math.
What are the side effects of Setmelanotide?
Hyperpigmentation (skin, moles, lips) most common — reversible upon discontinuation. Injection site reactions, nausea, headache. Generally well-tolerated.
Is Setmelanotide safe?
Setmelanotide has shown a favorable safety profile in research. FDA-approved (Imcivree) for genetic and acquired hypothalamic obesity. Prescription medication. All research should follow appropriate safety protocols.